MED-EL US announced today its DualSync technology, developed in partnership with Starkey Hearing, was awarded a Hearing Technology Innovator Award in the Bimodal Hearing Category
Continue reading at AudiologyOnline
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable clinical change — this is an award announcement for an existing bimodal technology partnership; no new efficacy data are presented.
Continued recognition of cross-manufacturer bimodal solutions underscores the clinical importance of cochlear implant and hearing aid coordination, and may prompt clinicians to evaluate DualSync compatibility in their bimodal fitting workflows.
- 01MED-EL and Starkey's DualSync technology won the 2026 Hearing Technology Innovator Award in the Bimodal Hearing category.
- 02DualSync enables synchronization between a cochlear implant on one ear and a hearing aid on the other (bimodal hearing).
- 03This is the second time this partnership has won in this category.
- 04No new clinical efficacy data accompanied the announcement.
- 05Cross-manufacturer bimodal solutions remain relatively uncommon in the industry.
MED-EL and Starkey's DualSync bimodal technology won a 2026 Hearing Technology Innovator Award in the Bimodal Hearing category.
press releasesupportedMED-EL and Starkey have won this award again, implying a prior win in the same category.
press releasepartially supported